Literature DB >> 9034827

Dying-back oligodendrogliopathy: a late sequel of myelin-associated glycoprotein deficiency.

H Lassmann1, U Bartsch, D Montag, M Schachner.   

Abstract

Ultrastructural analysis of myelin from 8-month-old mice deficient in the myelin-associated glycoprotein revealed pronounced and characteristic alterations of the periaxonal oligodendrocyte processes, consisting of intracytoplasmic deposition of vesicular material, multivesicular bodies, mitochondria, and lipofuscin granules, as well as granular or paracrystalline inclusions. These alterations are similar to those described before as "dying-back oligodendrogliopathy" in diseases of toxic or immune-mediated demyelination including multiple sclerosis.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9034827

Source DB:  PubMed          Journal:  Glia        ISSN： 0894-1491            Impact factor:   7.452


  20 in total

Review 1.  Multivesicular bodies in neurons: distribution, protein content, and trafficking functions.

Authors:  Christopher S Von Bartheld; Amy L Altick
Journal:  Prog Neurobiol       Date:  2011-01-07       Impact factor: 11.685

Review 2.  Extracellular regulators of axonal growth in the adult central nervous system.

Authors:  Betty P Liu; William B J Cafferty; Stephane O Budel; Stephen M Strittmatter
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-09-29       Impact factor: 6.237

3.  Lipid signature of neural tissues of marine and terrestrial mammals: consistency across species and habitats.

Authors:  Hillary L Glandon; Ai Ning Loh; William A McLellan; D Ann Pabst; Andrew J Westgate; Heather N Koopman
Journal:  J Comp Physiol B       Date:  2021-05-11       Impact factor: 2.200

Review 4.  Central nervous system regeneration inhibitors and their intracellular substrates.

Authors:  Michelle Nash; Horia Pribiag; Alyson E Fournier; Christian Jacobson
Journal:  Mol Neurobiol       Date:  2009-09-19       Impact factor: 5.590

5.  Myelin-associated glycoprotein gene mutation causes Pelizaeus-Merzbacher disease-like disorder.

Authors:  Alexander Lossos; Nimrod Elazar; Israela Lerer; Ora Schueler-Furman; Yakov Fellig; Benjamin Glick; Bat-El Zimmerman; Haim Azulay; Shlomo Dotan; Sharon Goldberg; John M Gomori; Penina Ponger; J P Newman; Hodaifah Marreed; Andreas J Steck; Nicole Schaeren-Wiemers; Nofar Mor; Michal Harel; Tamar Geiger; Yael Eshed-Eisenbach; Vardiella Meiner; Elior Peles
Journal:  Brain       Date:  2015-07-15       Impact factor: 13.501

6.  Mice lacking Gpr37 exhibit decreased expression of the myelin-associated glycoprotein MAG and increased susceptibility to demyelination.

Authors:  Brilee M Smith; Michelle M Giddens; Jessica Neil; Sharon Owino; TrangKimberly T Nguyen; Duc Duong; Fengqiao Li; Randy A Hall
Journal:  Neuroscience       Date:  2017-06-20       Impact factor: 3.590

7.  The cytoplasmic domain of the large myelin-associated glycoprotein isoform is needed for proper CNS but not peripheral nervous system myelination.

Authors:  N Fujita; A Kemper; J Dupree; H Nakayasu; U Bartsch; M Schachner; N Maeda; K Suzuki; B Popko
Journal:  J Neurosci       Date:  1998-03-15       Impact factor: 6.167

8.  Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single- and double-null mice.

Authors:  Baohan Pan; Susan E Fromholt; Ellen J Hess; Thomas O Crawford; John W Griffin; Kazim A Sheikh; Ronald L Schnaar
Journal:  Exp Neurol       Date:  2005-09       Impact factor: 5.330

9.  Short-term cuprizone feeding verifies N-acetylaspartate quantification as a marker of neurodegeneration.

Authors:  Barbara Maria Krauspe; Wolfgang Dreher; Cordian Beyer; Werner Baumgartner; Bernd Denecke; Katharina Janssen; Claus-Dieter Langhans; Tim Clarner; Markus Kipp
Journal:  J Mol Neurosci       Date:  2014-09-05       Impact factor: 3.444

10.  The effects of normal aging on myelinated nerve fibers in monkey central nervous system.

Authors:  Alan Peters
Journal:  Front Neuroanat       Date:  2009-07-06       Impact factor: 3.856
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.